[
  "Luigi Rovati  founded specialty drug maker Rottapharm; it started as an independent research lab in 1961.",
  "He sold Rottapharm to Swedish drugmaker Meda in 2014 for $3.1 billion in cash and stock. ",
  "In 2016, Meda was acquired by U.S. pharmaceutical firm Mylan for $7.2 billion in cash and stock, and Rovati now owns a small stake in Mylan.",
  "Rovati is no longer involved with the company he founded."
]